With the summer reporting season now upon us, those looking for some relief amidst the bearish gloom are likely to be disappointed. Whilst pharmaceutical stocks like AstraZeneca staged a recovery last… more →
The Reckoningwrote 1 year ago: With the summer reporting season now upon us, those looking for some relief amidst the bearish gloom … more →
wrote 1 year ago: Careful there! Tread quietly! We are now in official bear territory. Who knows what dangers lurk in … more →
wrote 1 year ago: This time it’s different – the plangent refrain of the investor suffocating in a bubble. Ah, what bl … more →
wrote 1 year ago: The credit crunch has had a surprisingly positive impact on the UK-based managers ploughing the spec … more →
wrote 1 year ago: Market commentators are fond of historical parallels. As the UK consumer is finally waking up to the … more →
wrote 1 year ago: Small caps have been out of favour since the economy took a turn for the worse last November. If we’ … more →
wrote 1 year ago: At the back end of last year there was one thing that everyone agreed on, even if they couldn’t agre … more →